Intravenous Immunoglobulin Market Size is estimated to grow at a CAGR of 7.0% during the forecast period
During the projected period of 2022–2030, the global intravenous immunoglobulin market is anticipated to expand at a compound annual growth rate (CAGR) of 7.0%. Intravenous immunoglobulin (IVIG) is a blood product or therapy used to treat a variety of illnesses, such as immune thrombocytopenic purpura, hypogammaglobulinemia, Kawasaki disease, Guillain-Barré syndrome, primary immunodeficiency, chronic inflammatory demyelinating polyneuropathy, some cases of HIV/AIDS and measles, and various other infectious diseases. It can be injected into a vein, a muscle, or beneath the skin, depending on how it is made. IVIg is useful for maintaining the proper level of antibodies in the bodies of people or patients who are unable to manufacture enough antibodies. ...